Drug Description in Trials / DrugBank / KEGG DRUG
Search results
Showing 1 to 10 of 86 drugs
| No. | KEGG DRUG | DrugBank | 薬物名（臨床試験情報から抽出） | KEGG GENES | KEGG PATHWAY | 指定難病告示番号 | ||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 |
Edetic acid
1. Edetic acid
| 1件: Edetic acid Edetic acid | 1件: EDTA EDTA | - | - | 1件: 60 60 💬1. Edetic acid
| ||||||||||||||||||||||||||||||||||||||||
| 2 |
Epinephrine
2. Epinephrine
| 1件: Epinephrine Epinephrine | 3件: Epinephrine Epinephrine; Lidocaine; Xylocaine | 9件: ADRA1A ADRA1A,ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 | 14件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 14件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chem ... | 3件: 46 46, 70, 96 💬
| ||||||||||||||||||||||||||||||||||||||||
| 3 |
Estradiol
3. Estradiol
| 1件: Estradiol Estradiol | 1件: Estradiol Estradiol | 2件: ESR1 ESR1,ESR2 💬 | 10件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 10件: Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regula ... | 7件: 13 13, 46, 49, 65, 76, 226, 299 💬3. Estradiol
| ||||||||||||||||||||||||||||||||||||||||
| 4 |
Epoprostenol
4. Epoprostenol
| 1件: Epoprostenol Epoprostenol | 6件: EPOPROSTENOL EPOPROSTENOL; Epoprostenol for injection; EPOPROSTENOL SODIUM; Flolan; Prostacyclin; Veletri | 1件: PTGIR PTGIR 💬4. Epoprostenol
| 3件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction ... | 1件: 86 86 💬4. Epoprostenol
| ||||||||||||||||||||||||||||||||||||||||
| 5 |
Ephedrine
5. Ephedrine
| 1件: Ephedrine Ephedrine | 3件: Efedrina Efedrina; Ephedrine; EPHEDRINE HYDROCHLORIDE | 9件: ADRA1A ADRA1A,ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 | 14件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 14件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chem ... | 1件: 11 11 💬5. Ephedrine
| ||||||||||||||||||||||||||||||||||||||||
| 6 |
Etoposide
6. Etoposide
| 1件: Etoposide Etoposide | 1件: Etoposide Etoposide | 2件: TOP2A TOP2A,TOP2B 💬 | 1件: Platinum drug resistance Platinum drug resistance 💬 | 11件: 11 11, 13, 14, 26, 28, 34, 60, 65, 85, 164, 331 💬6. Etoposide
| ||||||||||||||||||||||||||||||||||||||||
| 7 |
Erythromycin
7. Erythromycin
| 1件: Erythromycin Erythromycin | 1件: Erythromycin Erythromycin | - | - | 5件: 6 6, 36, 164, 228, 291 💬
| ||||||||||||||||||||||||||||||||||||||||
| 8 |
Estriol
8. Estriol
| 1件: Estriol Estriol | 1件: Estriol Estriol | 2件: ESR1 ESR1,ESR2 💬 | 10件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 10件: Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regula ... | 2件: 13 13, 227 💬
| ||||||||||||||||||||||||||||||||||||||||
| 9 |
Ergocalciferol
9. Ergocalciferol
| 1件: Ergocalciferol Ergocalciferol | 3件: Ergocalciferol Ergocalciferol; Vitamin D; Vitamin D2 | 1件: VDR VDR 💬9. Ergocalciferol
| 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reab ... | 6件: 46 46, 49, 84, 96, 97, 299 💬
| ||||||||||||||||||||||||||||||||||||||||
| 10 |
Etodolac
10. Etodolac
| 1件: Etodolac Etodolac | 1件: Etodolac Etodolac | 1件: PTGS2 PTGS2 💬10. Etodolac
| 22件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 22件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemi ... | 1件: 46 46 💬10. Etodolac
|